Feed GMED
GM

Globus Medical

GMED · NYSE

$75.79 +2.16% (+$1.60)
1M -12.84%
Market Cap $10.2B
P/E Ratio 19.09x
Div. Yield -
ROE 11.59%

Bulios Fair Price

$95.09

25.5% upside

Current Price

$75.79

Undervalued Fair Value Overvalued

According to Bulios Fair Price, GMED is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Strong
7/9
Valuation
76 /100
Cheap
P/FCF 13.62x
P/E 19.09x
P/B 2.14x
Growth
100 /100
Growing
FCF growth 77.99%
EPS growth 28.44%
Book val. growth 35.30%
Profitability
95 /100
Strong
Op. margin 20.75%
Gross margin 68.55%
FCF margin 23.87%
Quality
59 /100
Average
ROA 9.76%
ROIC 10.46%
Asset turnover 0.57x
Debt
100 /100
Low
Net debt/EBITDA -0.45x
Debt/Equity 0.02x
Current ratio 4.62x
Stability
52 /100
Moderate
EPS volatility 264.90%
Beta 0.96x
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about GMED
Online

About the company

Globus Medical, Inc. (GMED) is an American company specializing in the development, manufacturing, and distribution of orthopedic implants and surgical devices. With a wide portfolio of innovative products, Globus Medical is known for its efforts to improve treatment options for patients with spine conditions and injuries. The company focuses on providing high-quality and reliable products that help surgeons achieve optimal outcomes in surgical procedures. Globus Medical also invests in research and development of new technologies and products that enhance the lives of patients with musculoskeletal disorders. Globus Medical, Inc. (GMED) shares could be suitable for investors looking to invest in the healthcare sector with an emphasis on orthopedic implants and surgical devices.

Sector

Healthcare

Industry

Medical - Devices

CEO

Keith W. Pfeil

Employees

6,000

Headquarters

Audubon

Upcoming events

05 NOV

Earnings

Upcoming earnings report

51d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.